Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: recent chf admission major surgical or invasive procedure: coronary artery bypass graft x 4 (lima to lad, svg to diag, svg to om, svg to rca) history of present illness: 80 y/o male w/known cad, adm. to center for cardiac catheterization. this revealed severe 3vcad, and he was transferred to for cabg past medical history: acute on chronic chf social history: 120 pk/yr smoker, recently down to 3-4 cigarettes per day. drinks 1 beer per week family history: unknown physical exam: unremarkable upon admission pertinent results: cnis: there is a less than 40% right ica stenosis and a less than 40 left ica stenosis with antegrade flow in both vertebral arteries. vein mapping: bilaterally patent greater saphenous veins, with the patient standing, the above-mentioned diameters are noted. echo: pre-bypass: 1. no atrial septal defect is seen by 2d or color doppler. 2. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity size is normal. there is mild to moderate hypokinesis of the mid anterior, antero-septal and antero-lateral walls and dyskinesis of the anterior and antero-septal apex. 3. right ventricular chamber size and free wall motion are normal. 4. there are simple atheroma in the aortic root. there are simple atheroma in the aortic arch. there are complex (mobile) atheroma in the descending aorta. 5. there are three aortic valve leaflets. the aortic valve leaflets are mildly thickened. there is no aortic valve stenosis. trace aortic regurgitation is seen. 6. the mitral valve leaflets are mildly thickened. mild (1+) mitral regurgitation is seen. 7. moderate tricuspid regurgitation is seen. 8. significant pulmonic regurgitation is seen. 9. there is no pericardial effusion. post-bypass: for the post-bypass study, the patient was receiving vasoactive infusions including phenylephrine. 1. lv function is slightly improved. the area of dyskinesis in the antero-septal and anterior apex are resolved. rv function is . 2. mr 3. aorta is itnact post-decannulation 4. other findings are cxr: status post cabg. a single ap view of the chest is obtained at 05:10 hours and compared with the prior morning's radiograph. the left pleural tube has been removed. the tiny left apical pneumothorax seen yesterday has almost completely resolved. there persists increased density in the retrocardiac area on the left side consistent with atelectasis/airspace disease. the patient is developing some patchy densities at the right base, which also likely represent atelectasis or possibly early airspace disease. no large pleural effusions are present. 04:10pm blood wbc-7.8 rbc-4.88 hgb-12.7* hct-38.4* mcv-79* mch-26.1* mchc-33.2 rdw-14.3 plt ct-235 06:14am blood wbc-10.4 rbc-3.52* hgb-9.7* hct-27.7* mcv-79* mch-27.6 mchc-35.0 rdw-15.6* plt ct-229 04:10pm blood pt-12.5 ptt-54.2* inr(pt)-1.1 03:08am blood pt-12.2 ptt-37.9* inr(pt)-1.1 04:10pm blood glucose-90 urean-24* creat-1.4* na-134 k-4.6 cl-98 hco3-26 angap-15 06:14am blood urean-16 creat-1.2 k-3.9 brief hospital course: transferred from center to the cvicu on . taken to the or on for cabg x 4 (lima>lad, svg>diag, svg>om, svg>rca). please see operative report for details. post-operatively, he was taken to the cvicu. he was initially slow to wake from anesthesia, and extubated on pod # 1. he was weaned from vasoactive drips, and transferred to the telemetry unit later that day. he had some delerium at night for the first few nights, but this has cleared without intervention. he discontinued his left pleural chest tube, and subsequent cxr revealed no pneumothorax. he remained stable hemodynamically, and his antihypertensive medications were increased over the next few days. he did fail two voiding trials after foley removal, and will be discharged with a foley catheter. he will follow up with dr. , a urologist at center in as determined by his pcp, . . medications on admission: aspirin 81mg qd, lasix 20mg qd, lisinopril 20mg qd, lopressor 50mg , simvastatin 20mg qd discharge medications: 1. ranitidine sig: one (1) po twice a day. disp:*60 tabs* refills:*2* 2. docusate sig: one (1) po twice a day. disp:*60 caps* refills:*2* 3. aspirin sig: one (1) po once a day. disp:*30 tabs* refills:*2* 4. oxycodone sig: po every four (4) hours as needed for pain. disp:*40 tabs* refills:*0* 5. simvastatin sig: one (1) tab po once a day. disp:*30 tab* refills:*2* 6. clopidogrel sig: one (1) tab po once a day. disp:*30 tab* refills:*2* 7. metoprolol sig: one (1) tab po once a day. disp:*30 tab* refills:*2* 8. lisinopril sig: one (1) tab po once a day. disp:*30 tab* refills:*2* 9. tamsulosin sig: one (1) tab po once a day. disp:*30 tab* refills:*2* 10. furosemide sig: one (1) tab po once a day for 7 days. disp:*7 tab* refills:*0* 11. potassium sig: two (2) caps po once a day for 7 days. disp:*14 caps* refills:*0* discharge disposition: home with service facility: vna of greater ri discharge diagnosis: coronary artery disease s/p coronary artery bypass graft x 4 pmh: myocardial infarction , congestive heart failure, hypertension, abdominal aortic aneurysm, diabetes mellitus (diet controlled), peripheral vascular disease s/p cea discharge condition: good discharge instructions: 1)please shower daily. no baths. pat dry incisions, do not rub. 2)avoid creams and lotions to surgical incisions. 3)call cardiac surgeon if there is concern for wound infection. 4)no lifting more than 10 lbs for at least 10 weeks from surgical date. 5)no driving for at least one month. followup instructions: dr. ( dr. in 4 weeks ( dr. within 1 week ( dr. in weeks ( clinic on 2 in 2 weeks procedure: (aorto)coronary bypass of three coronary arteries single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart diagnoses: anemia, unspecified coronary atherosclerosis of native coronary artery tobacco use disorder congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication old myocardial infarction chronic systolic heart failure retention of urine, unspecified abdominal aneurysm without mention of rupture 

Answer: The patient is high likely exposed to